🔎 Trials Near Me

Home › Burkitt Lymphoma › Washington

Pag-aaral pangklinika para sa Burkitt Lymphoma sa Washington

14 pag-aaral para sa Burkitt Lymphoma ang naghahanap ng mga kalahok sa mga site sa Washington.

Mga Lungsod sa Washington

Opisyal na teksto ng pag-aaral (English)

A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL)

  • Seattle Children's Hospital, Seattle
Nagre-recruitPhase 1
Edad 0 hanggang 18 · Lahat ng kasarian · Na-update Nob 13, 2026 · NCT06173518

Asciminib and Inotuzumab Ozogamicin for Relapsed or Refractory Philadelphia Chromosome-positive B-cell Acute Lymphoblastic Leukemia (R/R Ph+ B-ALL)

  • University of Washington Fred Hutchinson Comprehensive Cancer Center, Seattle
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 13, 2026 · NCT07936266

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

  • Seattle Children's Hospital, Seattle
  • Providence Sacred Heart Medical Center and Children's Hospital, Spokane
  • Mary Bridge Children's Hospital and Health Center, Tacoma
  • at 1 pa
Nagre-recruitPhase 2
Edad 1 hanggang 30 · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT04546399

Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia

  • Swedish Cancer Institute-Edmonds, Edmonds
  • Swedish Medical Center-First Hill, Seattle
Nagre-recruitPhase 3
Edad 18 hanggang 39 · Lahat ng kasarian · Na-update Nob 3, 2026 · NCT03150693

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

  • Seattle Children's Hospital, Seattle
  • Providence Sacred Heart Medical Center and Children's Hospital, Spokane
Nagre-recruitPhase 2
365 Days · Lahat ng kasarian · Na-update Okt 27, 2026 · NCT06317662

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

  • Seattle Children's Hospital, Seattle
  • Providence Sacred Heart Medical Center and Children's Hospital, Spokane
  • Mary Bridge Children's Hospital and Health Center, Tacoma
Nagre-recruitPhase 2
366 Days – 46 Years · Lahat ng kasarian · Na-update Okt 27, 2026 · NCT06124157

Epcoritamab With Dose Adjusted Etoposide, Cyclophosphamide, Vincristine, Doxorubicin, Prednisone and Rituximab (EPOCH-R) for the Treatment of Aggressive B-Cell Non-Hodgkin Lymphoma

  • Fred Hutch/University of Washington Cancer Consortium, Seattle
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 21, 2026 · NCT07097363

Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies

  • Fred Hutchinson Cancer Research Center, Seattle
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 14, 2026 · NCT07648264

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

  • Seattle Children's Hospital, Seattle
  • Providence Sacred Heart Medical Center and Children's Hospital, Spokane
  • Mary Bridge Children's Hospital and Health Center, Tacoma
Nagre-recruitPhase 3
365 Days – 25 Years · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT03959085

Evaluating the Effects of Hemoglobin Threshold-specific Packed Red Blood Cell Transfusions on Quality of Life and Functional Outcomes in Patients With High-grade Myeloid Neoplasms, Acute Myeloid Leukemia, or B Acute Lymphoblastic Lymphoma/Leukemia

  • Fred Hutch/University of Washington Cancer Consortium, Seattle
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 19, 2026 · NCT06710418

Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies

  • Fred Hutch/University of Washington Cancer Consortium, Seattle
Nagre-recruitPhase 2Malugod na tinatanggap ang malusog na boluntaryo
6 Months · Lahat ng kasarian · Na-update May 29, 2026 · NCT04195633

Study of SGR-1505 in Mature B-Cell Neoplasms

  • Fred Hutchinson Cancer Center, Seattle
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Peb 13, 2026 · NCT05544019

Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL

  • Fred Hutchinson Cancer Research Center, Seattle
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 5, 2025 · NCT04260022

Study of VIP943 in Subjects With Advanced CD123+ Hematologic Malignancies

  • Fred Hutchinson Cancer Center, Seattle
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 15, 2024 · NCT06034275

Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.